vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and GENESCO INC (GCO). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $616.2M, roughly 1.2× GENESCO INC). Healthpeak Properties runs the higher net margin — 73.2% vs 0.9%, a 72.3% gap on every dollar of revenue. On growth, GENESCO INC posted the faster year-over-year revenue change (3.3% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $-31.5M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -8.7%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Genesco Inc. is an American publicly owned specialty retailer of branded footwear and accessories and is a wholesaler of branded and licensed footwear based in Nashville, Tennessee. Founded back in 1924 as Jarman Shoe Company, a footwear manufacturer, the company changed its name to General Shoe Corporation in 1933, and became a public company in 1939. By 1957, its stock would be included in the first S&P 500 Index. The company took its current name, Genesco—an acronym derived from its earlie...

DOC vs GCO — Head-to-Head

Bigger by revenue
DOC
DOC
1.2× larger
DOC
$719.4M
$616.2M
GCO
Growing faster (revenue YoY)
GCO
GCO
+0.3% gap
GCO
3.3%
3.1%
DOC
Higher net margin
DOC
DOC
72.3% more per $
DOC
73.2%
0.9%
GCO
More free cash flow
DOC
DOC
$388.5M more FCF
DOC
$357.0M
$-31.5M
GCO
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-8.7%
GCO

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
DOC
DOC
GCO
GCO
Revenue
$719.4M
$616.2M
Net Profit
$114.0M
$5.4M
Gross Margin
46.8%
Operating Margin
17.4%
1.4%
Net Margin
73.2%
0.9%
Revenue YoY
3.1%
3.3%
Net Profit YoY
2406.4%
128.3%
EPS (diluted)
$0.16
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
GCO
GCO
Q4 25
$719.4M
$616.2M
Q3 25
$705.9M
$546.0M
Q2 25
$694.3M
$474.0M
Q1 25
$702.9M
$745.9M
Q4 24
$698.0M
$596.3M
Q3 24
$700.4M
$525.2M
Q2 24
$695.5M
$457.6M
Q1 24
$606.6M
$739.0M
Net Profit
DOC
DOC
GCO
GCO
Q4 25
$114.0M
$5.4M
Q3 25
$-117.1M
$-18.5M
Q2 25
$31.7M
$-21.2M
Q1 25
$42.8M
$34.4M
Q4 24
$4.5M
$-18.9M
Q3 24
$85.9M
$-10.0M
Q2 24
$146.0M
$-24.3M
Q1 24
$6.7M
$27.2M
Gross Margin
DOC
DOC
GCO
GCO
Q4 25
46.8%
Q3 25
58.6%
45.8%
Q2 25
60.2%
46.7%
Q1 25
61.1%
46.9%
Q4 24
60.3%
47.8%
Q3 24
60.0%
46.8%
Q2 24
60.6%
47.3%
Q1 24
59.8%
46.3%
Operating Margin
DOC
DOC
GCO
GCO
Q4 25
17.4%
1.4%
Q3 25
9.2%
-2.6%
Q2 25
5.7%
-5.9%
Q1 25
7.7%
6.2%
Q4 24
-2.2%
1.7%
Q3 24
14.1%
-2.0%
Q2 24
22.3%
-7.0%
Q1 24
3.7%
5.0%
Net Margin
DOC
DOC
GCO
GCO
Q4 25
73.2%
0.9%
Q3 25
-16.6%
-3.4%
Q2 25
4.6%
-4.5%
Q1 25
6.1%
4.6%
Q4 24
0.7%
-3.2%
Q3 24
12.3%
-1.9%
Q2 24
21.0%
-5.3%
Q1 24
1.1%
3.7%
EPS (diluted)
DOC
DOC
GCO
GCO
Q4 25
$0.16
$0.50
Q3 25
$-0.17
$-1.79
Q2 25
$0.05
$-2.02
Q1 25
$0.06
$3.16
Q4 24
$0.02
$-1.76
Q3 24
$0.12
$-0.91
Q2 24
$0.21
$-2.23
Q1 24
$0.01
$2.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
GCO
GCO
Cash + ST InvestmentsLiquidity on hand
$467.5M
$27.0M
Total DebtLower is stronger
$9.8B
$89.5M
Stockholders' EquityBook value
$7.5B
$513.8M
Total Assets
$20.3B
$1.5B
Debt / EquityLower = less leverage
1.31×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
GCO
GCO
Q4 25
$467.5M
$27.0M
Q3 25
$91.0M
$41.0M
Q2 25
$89.4M
$21.7M
Q1 25
$70.6M
$34.0M
Q4 24
$119.8M
$33.6M
Q3 24
$180.4M
$45.9M
Q2 24
$106.9M
$19.2M
Q1 24
$101.8M
$35.2M
Total Debt
DOC
DOC
GCO
GCO
Q4 25
$9.8B
$89.5M
Q3 25
$9.1B
$71.0M
Q2 25
$9.0B
$121.0M
Q1 25
$8.9B
$0
Q4 24
$8.7B
$100.1M
Q3 24
$8.6B
$77.8M
Q2 24
$8.6B
$59.4M
Q1 24
$8.8B
$34.7M
Stockholders' Equity
DOC
DOC
GCO
GCO
Q4 25
$7.5B
$513.8M
Q3 25
$7.6B
$506.4M
Q2 25
$7.9B
$522.2M
Q1 25
$8.2B
$547.0M
Q4 24
$8.4B
$516.9M
Q3 24
$8.6B
$532.6M
Q2 24
$8.8B
$548.5M
Q1 24
$8.9B
$571.2M
Total Assets
DOC
DOC
GCO
GCO
Q4 25
$20.3B
$1.5B
Q3 25
$19.6B
$1.4B
Q2 25
$19.8B
$1.4B
Q1 25
$19.8B
$1.3B
Q4 24
$19.9B
$1.4B
Q3 24
$20.0B
$1.4B
Q2 24
$20.2B
$1.3B
Q1 24
$20.5B
$1.3B
Debt / Equity
DOC
DOC
GCO
GCO
Q4 25
1.31×
0.17×
Q3 25
1.20×
0.14×
Q2 25
1.14×
0.23×
Q1 25
1.08×
0.00×
Q4 24
1.04×
0.19×
Q3 24
1.00×
0.15×
Q2 24
0.98×
0.11×
Q1 24
0.99×
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
GCO
GCO
Operating Cash FlowLast quarter
$1.3B
$-12.9M
Free Cash FlowOCF − Capex
$357.0M
$-31.5M
FCF MarginFCF / Revenue
49.6%
-5.1%
Capex IntensityCapex / Revenue
124.4%
3.0%
Cash ConversionOCF / Net Profit
10.99×
-2.41×
TTM Free Cash FlowTrailing 4 quarters
$23.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
GCO
GCO
Q4 25
$1.3B
$-12.9M
Q3 25
$315.0M
$86.3M
Q2 25
$363.5M
$-101.0M
Q1 25
$279.4M
$117.0M
Q4 24
$1.1B
$-23.1M
Q3 24
$318.2M
$27.7M
Q2 24
$316.2M
$-33.7M
Q1 24
$152.6M
$118.3M
Free Cash Flow
DOC
DOC
GCO
GCO
Q4 25
$357.0M
$-31.5M
Q3 25
$71.7M
Q2 25
$-119.9M
Q1 25
$103.3M
Q4 24
$333.7M
$-36.2M
Q3 24
$19.8M
Q2 24
$-40.1M
Q1 24
$107.8M
FCF Margin
DOC
DOC
GCO
GCO
Q4 25
49.6%
-5.1%
Q3 25
13.1%
Q2 25
-25.3%
Q1 25
13.8%
Q4 24
47.8%
-6.1%
Q3 24
3.8%
Q2 24
-8.8%
Q1 24
14.6%
Capex Intensity
DOC
DOC
GCO
GCO
Q4 25
124.4%
3.0%
Q3 25
2.7%
Q2 25
4.0%
Q1 25
1.8%
Q4 24
105.6%
2.2%
Q3 24
1.5%
Q2 24
1.4%
Q1 24
1.4%
Cash Conversion
DOC
DOC
GCO
GCO
Q4 25
10.99×
-2.41×
Q3 25
Q2 25
11.48×
Q1 25
6.52×
3.40×
Q4 24
235.43×
Q3 24
3.71×
Q2 24
2.17×
Q1 24
22.85×
4.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOC
DOC

Segment breakdown not available.

GCO
GCO

Journeys Group Segment$376.7M61%
Schuh Group Segment$123.8M20%
Johnston And Murphy Group Segment$81.2M13%
Genesco Brands Segment$34.6M6%
Store Restructuring$3.9M1%

Related Comparisons